China Cord Blood (NYSE:CO) will issue its quarterly earnings data after the market closes on Thursday, February 22nd.
China Cord Blood (NYSE:CO) last released its quarterly earnings data on Monday, November 20th. The medical research company reported $0.09 EPS for the quarter. The firm had revenue of $35.26 million for the quarter. China Cord Blood had a net margin of 26.79% and a return on equity of 9.68%.
Shares of China Cord Blood (CO) opened at $10.29 on Thursday. The company has a market cap of $1,233.78, a PE ratio of 29.40 and a beta of 0.91. China Cord Blood has a fifty-two week low of $5.06 and a fifty-two week high of $14.95.
TRADEMARK VIOLATION WARNING: “China Cord Blood (CO) to Release Quarterly Earnings on Thursday” was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/02/15/china-cord-blood-co-to-release-quarterly-earnings-on-thursday.html.
China Cord Blood Company Profile
China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee.
Receive News & Ratings for China Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.